Discovery of Biomarkers of Intake of of Highly Consumed Foods in Mexico

NCT ID: NCT06449170

Last Updated: 2024-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine diet-health associations, researchers rely on information obtained from dietary instruments, such as the 24-hour recall (R24H), food frequency questionnaires (FFQ) and food diaries, in clinical studies. However, it is widely recognized that the information provided by the different instruments is biased by different factors including recall errors and respondent burden. The impact of the variability produced by this bias decreases the robustness of diet-health associations which results in the creation of less efficient standards and recommendations for our population. To address this, the discovery of biomarkers of food intake (BFIs) is an objective tool that indicates exposure to specific foods or various dietary patterns. BFIs allow the calibration of dietary information to obtain the real consumption of the individual and thus clarify the relationship between different pathologies of interest and the intake of different foods. BIAMEX will initially focus on the discovery of BFIs of nopal, corn tortilla, mango, avocado, guava and amaranth. For this purpose, a controlled crossover intervention study is being carried out with the 6 foods to be investigated where 24h urine and plasma samples are being collected. Subsequently, the samples collected will be analyzed by mass spectrometry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The BIAMEX study aims to address the challenge of improving the accuracy of dietary assessment, a critical factor in misunderstanding the relationship between diet and disease. Traditional dietary assessment tools, such as 24-hour recalls and food frequency questionnaires, are susceptible to biases related to their retrospective nature, such as memory errors and respondent burden. To overcome these limitations, BIAMEX focuses on discovering biomarkers on food intake (BFIs) for foods that originate in our country and are highly consumed by the population. This project will investigate the BFIs for nopal, corn tortilla, mango, avocado, guava, and amaranth.

This exploratory study employs a randomized, open, crossover, controlled design to investigate the metabolomic changes in urine and serum samples from healthy volunteers following the consumption of the selected foods. The interventions aim to assess the impact of each food intake on the metabolomic profile of the participants using an untargeted approach with liquid chromatography-mass spectrometry.

Participants were briefed at the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" on the study's aims, procedures, and benefits before providing informed consent. Subsequent steps included clinical history documentation and blood sampling for eligibility assessment, focusing on fasting glucose, cholesterol levels, and other health indicators. Volunteers underwent seven distinct food interventions in a randomized manner, including mango, avocado, nopal, corn tortillas, guavas, amaranth, and Supportan® drink Cappuccino as the control. This beverage was chosen to avoid metabolomic overlap with the different foods, ensuring distinct biomarker detection. Preceding the intervention days, subjects followed a low-polyphenol diet, excluding test foods and phytochemicals-rich items such as tea, coffee, or chocolate, culminating in a standardized dinner. On the intervention day, subjects arrived fasting at the institution and provided a baseline serum and urine samples. Then, subjects were provided with the test food, after which urine and serum samples were collected at 1h, 2h,4h, 6h postprandially on site. After the six-hour timepoint, the catheter was removed, and a standardized lunch was provided. Subjects continued to collect urine samples at home, corresponding to the 12h and 24h urine collection, using materials provided by the investigation team. Additionally, subjects received dietary instructions and menus to follow for the rest of the day. On the day after the intervention, subjects returned to the institution to deliver the urine collections and to provide the last serum sample corresponding to the 24-hour timepoint. Once the sample was collected, subjects were provided with a complimentary breakfast, and their habitual diet was resumed. This experimental procedure was repeated for each food separated by a 7-day wash-out period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition, Healthy Diet Habit Diet, Healthy Dietary Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This is a randomized, open, crossover, and controlled design study. A total of 12 healthy subjects (six males and six females) aged 18-40 years with a BMI of 18.5-24.9 kg/m\^2 were recruited. Participants underwent seven interventions (each featuring one of the selected foods or a control beverage), with a washout period of 7 days between interventions.

Each intervention is as follows:

150g of mango + 150ml of control beverage, 120g of avocado + 150ml of control beverage, 300g of cooked nopal + 150ml of control beverage, 3 corn tortillas + 150ml of control beverage, 3 guavas + 150ml of control beverage,

½ cup of amaranth + 150ml of control beverage, 290ml of control beverage
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mango Ataulfo

150g of mango Ataulfo plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 15ml of sunflower seed oil

Group Type OTHER

Mango Ataulfo

Intervention Type OTHER

In this intervention, subjects consumed 150g of mango Ataulfo plus 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage has the purpose of providing energy intake and limiting the noise that the control beverage may contribute to the metabolomic profile in urine and serum.

Avocado Hass

120g of avocado hass plus 150ml of control beverage (Supportan® Drink Cappuccino)

Group Type OTHER

Avocado Hass

Intervention Type OTHER

In this intervention, subjects consumed 120g of avocado hass plus 150 ml of a control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolomic profile in urine and serum.

Boiled Nopal

300g of boiled nopal plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 18ml of sunflower seed oil

Group Type OTHER

Nopal

Intervention Type OTHER

In this intervention, subjects consumed 300g of cooked nopal and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Corn Tortilla

3 pieces of corn tortilla plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 2ml of sunflower seed oil

Group Type OTHER

3 corn tortilla

Intervention Type OTHER

In this intervention, subjects consumed 3 corn tortillas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Guava

3 pieces of guava plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 16ml of sunflower seed oil

Group Type OTHER

Guava

Intervention Type OTHER

In this intervention, subjects consumed 3 guavas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Amaranth

1/2 cup of amaranth plus 150 ml of control beverage (Supportan® Drink Cappuccino) plus 35ml of sunflower seed oil

Group Type OTHER

Amaranth

Intervention Type OTHER

In this intervention, subjects consumed 1/2 cup of amaranth and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Supportan® DKN Cappuccino

290ml of control beverage (Supportan® Drink Cappuccino)

Group Type OTHER

Control Beverage (Supportan Drink ® Capuccino)

Intervention Type DIETARY_SUPPLEMENT

In this intervention, subjects consumed 290ml of Supportan Drink ® Capuccino to act as a control for the metabolomic profiling in urine and serum.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mango Ataulfo

In this intervention, subjects consumed 150g of mango Ataulfo plus 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage has the purpose of providing energy intake and limiting the noise that the control beverage may contribute to the metabolomic profile in urine and serum.

Intervention Type OTHER

Avocado Hass

In this intervention, subjects consumed 120g of avocado hass plus 150 ml of a control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolomic profile in urine and serum.

Intervention Type OTHER

Nopal

In this intervention, subjects consumed 300g of cooked nopal and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Intervention Type OTHER

3 corn tortilla

In this intervention, subjects consumed 3 corn tortillas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Intervention Type OTHER

Guava

In this intervention, subjects consumed 3 guavas and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Intervention Type OTHER

Amaranth

In this intervention, subjects consumed 1/2 cup of amaranth and 150 ml of control beverage (Supportan® Drink Cappuccino). The addition of the control beverage provides energy intake and limits the noise that the beverage may contribute to the metabolic profile in urine and serum.

Intervention Type OTHER

Control Beverage (Supportan Drink ® Capuccino)

In this intervention, subjects consumed 290ml of Supportan Drink ® Capuccino to act as a control for the metabolomic profiling in urine and serum.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Healthy males and females
* BMI \>18.5 and \< 25 kg/m2
* Willing/able to consume all test foods and the standardized meals

Exclusion Criteria

* Smokers
* Diagnosed health condition (chronic or infectious disease)
* Taking nutritional supplements (e.g. vitamins, minerals) several times a week.
* Taking medication.
* Pregnant, lactating.
* Antibiotics treatment within 3 months prior to intervention.
* Vegetarians, as standardized meals will contain meat.
* Not willing to follow nutritional restrictions, including drinking alcohol during study days
* Allergic to foods of interest
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Natalia Vázquez Manjarrez

Researcher in Medical Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natalia Vázquez Manjarrez, PhD

Role: PRINCIPAL_INVESTIGATOR

National Institute of Medical Sciences and Nutrition Salvador Zubirán

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Instituto de Ciencias Médicas y Nutrición Salvador Zubirán

Mexico City, , Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

References

Explore related publications, articles, or registry entries linked to this study.

Archer E, Marlow ML, Lavie CJ. Controversy and debate: Memory-Based Methods Paper 1: the fatal flaws of food frequency questionnaires and other memory-based dietary assessment methods. J Clin Epidemiol. 2018 Dec;104:113-124. doi: 10.1016/j.jclinepi.2018.08.003. Epub 2018 Aug 17.

Reference Type BACKGROUND
PMID: 30121379 (View on PubMed)

Tinker LF, Sarto GE, Howard BV, Huang Y, Neuhouser ML, Mossavar-Rahmani Y, Beasley JM, Margolis KL, Eaton CB, Phillips LS, Prentice RL. Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am J Clin Nutr. 2011 Dec;94(6):1600-6. doi: 10.3945/ajcn.111.018648. Epub 2011 Nov 9.

Reference Type BACKGROUND
PMID: 22071707 (View on PubMed)

Vanderslice JT, Higgs DJ. Vitamin C content of foods: sample variability. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1323S-1327S. doi: 10.1093/ajcn/54.6.1323s.

Reference Type BACKGROUND
PMID: 1962591 (View on PubMed)

Andersen MB, Kristensen M, Manach C, Pujos-Guillot E, Poulsen SK, Larsen TM, Astrup A, Dragsted L. Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomics. Anal Bioanal Chem. 2014 Mar;406(7):1829-44. doi: 10.1007/s00216-013-7498-5. Epub 2014 Jan 4.

Reference Type BACKGROUND
PMID: 24390407 (View on PubMed)

Gibbons H, Michielsen CJR, Rundle M, Frost G, McNulty BA, Nugent AP, Walton J, Flynn A, Gibney MJ, Brennan L. Demonstration of the utility of biomarkers for dietary intake assessment; proline betaine as an example. Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201700037. Epub 2017 Jul 20.

Reference Type BACKGROUND
PMID: 28556565 (View on PubMed)

Cuparencu C, Rinnan A, Dragsted LO. Combined Markers to Assess Meat Intake-Human Metabolomic Studies of Discovery and Validation. Mol Nutr Food Res. 2019 Sep;63(17):e1900106. doi: 10.1002/mnfr.201900106. Epub 2019 Jun 13.

Reference Type BACKGROUND
PMID: 31141834 (View on PubMed)

Vazquez-Manjarrez N, Weinert CH, Ulaszewska MM, Mack CI, Micheau P, Petera M, Durand S, Pujos-Guillot E, Egert B, Mattivi F, Bub A, Dragsted LO, Kulling SE, Manach C. Discovery and Validation of Banana Intake Biomarkers Using Untargeted Metabolomics in Human Intervention and Cross-sectional Studies. J Nutr. 2019 Oct 1;149(10):1701-1713. doi: 10.1093/jn/nxz125.

Reference Type BACKGROUND
PMID: 31240312 (View on PubMed)

Giesbertz P, Brandl B, Lee YM, Hauner H, Daniel H, Skurk T. Specificity, Dose Dependency, and Kinetics of Markers of Chicken and Beef Intake Using Targeted Quantitative LC-MS/MS: A Human Intervention Trial. Mol Nutr Food Res. 2020 Mar;64(5):e1900921. doi: 10.1002/mnfr.201900921. Epub 2020 Jan 29.

Reference Type BACKGROUND
PMID: 31916678 (View on PubMed)

Ulaszewska MM, Weinert CH, Trimigno A, Portmann R, Andres Lacueva C, Badertscher R, Brennan L, Brunius C, Bub A, Capozzi F, Cialie Rosso M, Cordero CE, Daniel H, Durand S, Egert B, Ferrario PG, Feskens EJM, Franceschi P, Garcia-Aloy M, Giacomoni F, Giesbertz P, Gonzalez-Dominguez R, Hanhineva K, Hemeryck LY, Kopka J, Kulling SE, Llorach R, Manach C, Mattivi F, Migne C, Munger LH, Ott B, Picone G, Pimentel G, Pujos-Guillot E, Riccadonna S, Rist MJ, Rombouts C, Rubert J, Skurk T, Sri Harsha PSC, Van Meulebroek L, Vanhaecke L, Vazquez-Fresno R, Wishart D, Vergeres G. Nutrimetabolomics: An Integrative Action for Metabolomic Analyses in Human Nutritional Studies. Mol Nutr Food Res. 2019 Jan;63(1):e1800384. doi: 10.1002/mnfr.201800384. Epub 2018 Oct 11.

Reference Type BACKGROUND
PMID: 30176196 (View on PubMed)

Dragsted LO, Gao Q, Scalbert A, Vergeres G, Kolehmainen M, Manach C, Brennan L, Afman LA, Wishart DS, Andres Lacueva C, Garcia-Aloy M, Verhagen H, Feskens EJM, Pratico G. Validation of biomarkers of food intake-critical assessment of candidate biomarkers. Genes Nutr. 2018 May 30;13:14. doi: 10.1186/s12263-018-0603-9. eCollection 2018.

Reference Type BACKGROUND
PMID: 29861790 (View on PubMed)

Barnes RC, Krenek KA, Meibohm B, Mertens-Talcott SU, Talcott ST. Urinary metabolites from mango (Mangifera indica L. cv. Keitt) galloyl derivatives and in vitro hydrolysis of gallotannins in physiological conditions. Mol Nutr Food Res. 2016 Mar;60(3):542-50. doi: 10.1002/mnfr.201500706. Epub 2016 Feb 2.

Reference Type BACKGROUND
PMID: 26640139 (View on PubMed)

Kim H, Castellon-Chicas MJ, Arbizu S, Talcott ST, Drury NL, Smith S, Mertens-Talcott SU. Mango (Mangifera indica L.) Polyphenols: Anti-Inflammatory Intestinal Microbial Health Benefits, and Associated Mechanisms of Actions. Molecules. 2021 May 6;26(9):2732. doi: 10.3390/molecules26092732.

Reference Type BACKGROUND
PMID: 34066494 (View on PubMed)

Ferreira CM, Vieira AT, Vinolo MA, Oliveira FA, Curi R, Martins Fdos S. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res. 2014;2014:689492. doi: 10.1155/2014/689492. Epub 2014 Sep 18.

Reference Type BACKGROUND
PMID: 25309932 (View on PubMed)

Dreher ML, Davenport AJ. Hass avocado composition and potential health effects. Crit Rev Food Sci Nutr. 2013;53(7):738-50. doi: 10.1080/10408398.2011.556759.

Reference Type BACKGROUND
PMID: 23638933 (View on PubMed)

Fulgoni VL 3rd, Dreher M, Davenport AJ. Avocado consumption is associated with better diet quality and nutrient intake, and lower metabolic syndrome risk in US adults: results from the National Health and Nutrition Examination Survey (NHANES) 2001-2008. Nutr J. 2013 Jan 2;12:1. doi: 10.1186/1475-2891-12-1.

Reference Type BACKGROUND
PMID: 23282226 (View on PubMed)

Vazquez-Manjarrez N, Ulaszewska M, Garcia-Aloy M, Mattivi F, Pratico G, Dragsted LO, Manach C. Biomarkers of intake for tropical fruits. Genes Nutr. 2020 Jun 19;15(1):11. doi: 10.1186/s12263-020-00670-4.

Reference Type BACKGROUND
PMID: 32560627 (View on PubMed)

Qin XJ, Yu Q, Yan H, Khan A, Feng MY, Li PP, Hao XJ, An LK, Liu HY. Meroterpenoids with Antitumor Activities from Guava (Psidium guajava). J Agric Food Chem. 2017 Jun 21;65(24):4993-4999. doi: 10.1021/acs.jafc.7b01762. Epub 2017 Jun 9.

Reference Type BACKGROUND
PMID: 28578580 (View on PubMed)

Kohlert C, van Rensen I, Marz R, Schindler G, Graefe EU, Veit M. Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med. 2000 Aug;66(6):495-505. doi: 10.1055/s-2000-8616.

Reference Type BACKGROUND
PMID: 10985073 (View on PubMed)

Pujos-Guillot E, Hubert J, Martin JF, Lyan B, Quintana M, Claude S, Chabanas B, Rothwell JA, Bennetau-Pelissero C, Scalbert A, Comte B, Hercberg S, Morand C, Galan P, Manach C. Mass spectrometry-based metabolomics for the discovery of biomarkers of fruit and vegetable intake: citrus fruit as a case study. J Proteome Res. 2013 Apr 5;12(4):1645-59. doi: 10.1021/pr300997c. Epub 2013 Mar 5.

Reference Type BACKGROUND
PMID: 23425595 (View on PubMed)

Lopez-Romero P, Pichardo-Ontiveros E, Avila-Nava A, Vazquez-Manjarrez N, Tovar AR, Pedraza-Chaverri J, Torres N. The effect of nopal (Opuntia ficus indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts. J Acad Nutr Diet. 2014 Nov;114(11):1811-8. doi: 10.1016/j.jand.2014.06.352. Epub 2014 Aug 12.

Reference Type BACKGROUND
PMID: 25132122 (View on PubMed)

Vazquez-Manjarrez N, Guevara-Cruz M, Flores-Lopez A, Pichardo-Ontiveros E, Tovar AR, Torres N. Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial. Clin Nutr. 2021 May;40(5):2527-2534. doi: 10.1016/j.clnu.2021.02.048. Epub 2021 Mar 6.

Reference Type BACKGROUND
PMID: 33932799 (View on PubMed)

Nkobole N, Prinsloo G. 1H-NMR and LC-MS Based Metabolomics Analysis of Wild and Cultivated Amaranthus spp. Molecules. 2021 Feb 4;26(4):795. doi: 10.3390/molecules26040795.

Reference Type BACKGROUND
PMID: 33557008 (View on PubMed)

Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, Zhang H, Drexler DM. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Feb 15;877(5-6):547-52. doi: 10.1016/j.jchromb.2009.01.007. Epub 2009 Jan 14.

Reference Type BACKGROUND
PMID: 19185549 (View on PubMed)

Kohl SM, Klein MS, Hochrein J, Oefner PJ, Spang R, Gronwald W. State-of-the art data normalization methods improve NMR-based metabolomic analysis. Metabolomics. 2012 Jun;8(Suppl 1):146-160. doi: 10.1007/s11306-011-0350-z. Epub 2011 Aug 12.

Reference Type BACKGROUND
PMID: 22593726 (View on PubMed)

Scalbert A, Brennan L, Manach C, Andres-Lacueva C, Dragsted LO, Draper J, Rappaport SM, van der Hooft JJ, Wishart DS. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014 Jun;99(6):1286-308. doi: 10.3945/ajcn.113.076133. Epub 2014 Apr 23.

Reference Type BACKGROUND
PMID: 24760973 (View on PubMed)

van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006 Jun 8;7:142. doi: 10.1186/1471-2164-7-142.

Reference Type BACKGROUND
PMID: 16762068 (View on PubMed)

Vinaixa M, Samino S, Saez I, Duran J, Guinovart JJ, Yanes O. A Guideline to Univariate Statistical Analysis for LC/MS-Based Untargeted Metabolomics-Derived Data. Metabolites. 2012 Oct 18;2(4):775-95. doi: 10.3390/metabo2040775.

Reference Type BACKGROUND
PMID: 24957762 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://foodb.ca/

The Food database

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4044

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Time-Restricted Feeding
NCT04884659 COMPLETED NA